HDC 8-K filing 3/6/2020 Item 8.01 Other Events. As

New Post Public Reply Private Reply Replies (0) Message Board
LocWolf
324
HDC 8-K filing 3/6/2020

Item 8.01 Other Events.

As previously disclosed, on February 7, 2020 two shareholders of Health Discovery Corporation (the “Company” or “HDC”), William F. Quirk, Jr. (“Quirk”) and Cindy Bear (“Bear”), filed a motion for a temporary restraining order and preliminary injunction in DeKalb County Superior Court. Among the items in the motion, Quirk and Bear requested to have a special meeting of the shareholders and Quick and Bear allege misconduct by the Company and its directors.

On March 2, 2020, having received no relief, Quirk and Bear dismissed their action in DeKalb County and filed a new lawsuit in Fulton County Superior Court based on substantially similar allegations and seeking similar relief. On March 4, 2020, the Fulton County court ordered a hearing on the emergency motion for a temporary restraining order against the Company for the following day.

At the hearing on March 5, 2020, Quirk and Bear presented their version of the facts through affidavits submitted by both Quirk and Bear, arguing that the affidavits supported the emergency relief they sought. The judge denied the motion and did not enter a temporary restraining order. The court set an evidentiary hearing on Quirk and Bear’s motion for a preliminary injunction for March 27, 2020.

As previously disclosed, the Company has been working to bring its regulatory and financial filings current by filing its annual report on Form 10-K. The Company continues to work toward completing this filing by March 31, 2020. In addition, the Company previously stated that it intends to schedule a shareholder meeting soon after filing the 10-K, but no later than June 30, 2020. The Company is targeting a potential shareholder meeting on May 27, 2020 . However, these dates may need to be adjusted solely because of the significant time and resources that the Company is being forced to spend refuting the baseless claims brought by Quirk and Bear.

The Company firmly denies Quirk and Bear’s claims and will continue to defend itself. This litigation will continue to unnecessarily deplete the Company’s resources to the detriment of all shareholders.

https://www.sec.gov/Archives/edgar/data/11417...3d1_8k.htm

Health Discovery Cp (HDVY) Stock Research Links

HDVY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Top 5 Most Recently Viewed Articles

Experience Hassle-Free Cloud Mining with BCC Mining's App

Updated Category News Views 248

Revolutionizing Cloud Mining with BCC Mining Cloud mining has witnessed significant advancements, particularly with the recent introduction of BCC Mining's mobile app. This development marks a new era for cryptocurrency enthusiasts, making it easier than ever to participate in mining activities. Users now have the flexibility to manage their mining operations from...

Continue Reading
CEFALY Launches Research Registry for Pregnant Women’s Migraine Relief

Updated Category News Views 197

CEFALY Introduces the Pregnancy Registry for Migraine Treatment Medical device company CEFALY Technology has recently announced the introduction of the CEFALY Pregnancy Registry, a research initiative aimed at assessing the safety of external trigeminal nerve stimulation (eTNS) for migraine treatment during pregnancy. The Challenge of Managing Migraines During Pregnancy...

Continue Reading
Velocity MSC Expands Offerings with Innovative 5G Communication Solution

Updated Category News Views 234

Velocity MSC Expands Offerings with Innovative 5G Communication Solution Velocity MSC, a trusted name in technological solutions, has announced an exciting addition to its service lineup. The company has incorporated DataRemote's advanced 90X1 5G Plain Old Telephone Service (POTS) replacement solution into its existing offerings. This innovative solution aligns with...

Continue Reading
Exploring the Growth of Interleukin-23 Inhibitors Market Ahead

Updated Category News Views 148

Interleukin-23 Inhibitors Market Overview The interleukin-23 inhibitors market is currently experiencing significant growth, fueled by the escalating prevalence of autoimmune diseases such as psoriasis and inflammatory bowel disease. With innovations in biologics and increasing acceptance of targeted therapies, the demand for these treatments continues to surge....

Continue Reading
Hexagon AB to Spin Off Asset Lifecycle Intelligence Division

Updated Category News Views 671

Hexagon Plans Spin-Off for Enhanced Focus and Growth Hexagon AB is embarking on an exciting journey towards the spin-off of its Asset Lifecycle Intelligence (ALI) division and associated businesses. This significant decision, made by the Board of Directors, aims to separate ALI into a new entity that will allow both Hexagon and the new organization, referred to as NewCo,...

Continue Reading